We are live on ! Find out more
UTHR icon

United Therapeutics
UTHR

334 hedge funds and large institutions have $7.13B invested in United Therapeutics in 2014 Q4 according to their latest regulatory filings, with 54 funds opening new positions, 93 increasing their positions, 147 reducing their positions, and 36 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more first-time investments, than exits

New positions opened: 54 | Existing positions closed: 36

5% more funds holding

Funds holding: 319 → 334 (+15)

5% more capital invested

Capital invested by funds: $6.8B → $7.13B (+$336M)

4% more call options, than puts

Call options by funds: $39.2M | Put options by funds: $37.8M

28% less funds holding in top 10

Funds holding in top 10: 18 → 13 (-5)

37% less repeat investments, than reductions

Existing positions increased: 93 | Existing positions reduced: 147

Holders
334
Holders Change
+15
Holders Change %
+4.7%
% of All Funds
8.91%
Holding in Top 10
13
Holding in Top 10 Change
-5
Holding in Top 10 Change %
-27.78%
% of All Funds
0.35%
New
54
Increased
93
Reduced
147
Closed
36
Calls
$39.2M
Puts
$37.8M
Net Calls
+$1.37M
Net Calls Change
+$239M

Top Buyers

1
SCM
Scopia Capital Management
New York
+$41.6M
2
AQR Capital Management
AQR Capital Management
Connecticut
+$41.6M
3
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$32.3M
4
IAM
Iridian Asset Management
Connecticut
+$30.4M
5
First Trust Advisors
First Trust Advisors
Illinois
+$27.1M

Top Sellers

1
HCM
Herndon Capital Management
Georgia
-$145M
2
Schroder Investment Management Group
Schroder Investment Management Group
United Kingdom
-$87.6M
3
WG
Winton Group
United Kingdom
-$48.4M
4
AL
AJO LP
Pennsylvania
-$39.3M
5
Los Angeles Capital Management
Los Angeles Capital Management
California
-$32.4M
Name Holding Trade Value Shares
Change 		Change in
Stake
Verition Fund Management
351
Verition Fund Management
Connecticut
– -$496K -3,854 Closed
QSS
352
Quantitative Systematic Strategies
Florida
– -$435K -3,276 Closed
VF
353
Virtu Financial
New York
– -$266K -2,066 Closed
RFC
354
Regions Financial Corp
Alabama
– -$253K -1,967 Closed
BPM
355
Bowling Portfolio Management
Ohio
– -$234K -1,819 Closed
BPGAM
356
BTG Pactual Global Asset Management
Bermuda
– -$228K -1,770 Closed
PI
357
PineBridge Investments
New York
– -$211K -1,638 Closed
CIBC Asset Management
358
CIBC Asset Management
Ontario, Canada
– -$210K -1,631 Closed
RCAG
359
Rehmann Capital Advisory Group
Michigan
– -$207K -1,610 Closed
MAM
360
Martingale Asset Management
Massachusetts
– -$207K -1,607 Closed
William Blair & Company
361
William Blair & Company
Illinois
– -$206K -1,600 Closed
HIMCH
362
Hartford Investment Management Co (HIMCO)
Connecticut
– -$206K -1,598 Closed
ST
363
Spot Trading
Illinois
– -$189K -1,472 Closed
BGIM
364
Brandywine Global Investment Management
Pennsylvania
– -$118K -916 Closed
IRS
365
Invictus RG (Singapore)
Singapore
– -$13K -101 Closed
PHK
366
Point72 Hong Kong
Hong Kong
– -$10K -75 Closed
Fifth Third Bancorp
367
Fifth Third Bancorp
Ohio
– -$9K -67 Closed
JG
368
Jefferies Group
New York
– -$2.32K -18 Closed
EMA
369
Efficient Market Advisors
California
– -$1K -5 Closed
W
370
Wealthfront
California
– +$129 +1 New
11 12 13 14
15

UTHR Hedge Fund Activity: Q4 2014 in Review

334 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in United Therapeutics (UTHR) for Q4 2014, worth a combined $7.13B — up 4.9% from $6.8B a quarter earlier.

Buyers outnumbered sellers: 54 funds opened new UTHR positions and 36 closed out — a net gain of 18 holders — while 93 added to existing stakes and 147 trimmed.

The largest buyer was Scopia Capital Management, adding an estimated $41.6M. The largest seller was Herndon Capital Management, cutting an estimated $145M.

  • 334 institutional investors held United Therapeutics (UTHR) as of Q4 2014, up from 319 in Q3 2014.
  • Funds reported $7.13B of United Therapeutics stock for Q4 2014, up 4.9% quarter-over-quarter.
  • 54 funds opened new United Therapeutics positions in Q4 2014 and 36 closed out, a net change of +18 holders.
  • The largest United Therapeutics buyer in Q4 2014 was Scopia Capital Management, an estimated $41.6M added.
  • The largest United Therapeutics seller in Q4 2014 was Herndon Capital Management, an estimated $145M sold.

Based on aggregated 13F filings for Q4 2014.